More than 50 companies of the biomedical sector have established facilities in Aragon
CerTest Biotec, a local manufacturer of antigen tests, will invest € 100 million euros in the next three years, creating 205 new jobs
Nowadays, around 50 pharmaceutical companies have established their installations in Aragon, manufacturing a variety of pharmaceutical products, radiation, electromedical and electrotherapeutic equipment, and medical and dental instruments and supplies.
BD‘s recent investment in Zaragoza has helped boosting the industrial sector in Aragon, and the pharmaceutical industry in particular. This project is part of its business unit specialized in the manufacture and marketing of preloaded drug administration systems, mainly glass syringes, that are supplied to pharmaceutical companies to be filled with the drugs they produce.
Other notable companies, in addition to Becton Dickinson, have also set their eyes on Aragon:
- Novaltia, the sixth pharmaceutical distribution company by national market share, has invested in two logistics centers in Zaragoza and Calatayud in 2020.
- One of the largest pharmaceutical companies in the world, Teva will invest 40 million until 2025 in its Zaragoza plant and will create new 60 jobs, to increase its production by 20%
- Alliance Healthcare has hired about 200 people – half of them in the company’s international digital innovation center WBA Digital – in Villanueva de Gállego.
Another project that is already being developed is part of the industrial park Polígono Río Gállego II, in San Mateo de Gállego, where local antigen test producer CerTest Biotec is installed and whose presence and expansion is serving as a tractor for the installation of other projects in the biomedical sector.
CerTest will invest € 100 million in the next three years creating 205 new jobs. After the seventh phase of its initial development project to double the area and number of employees, construction of a vaccine factory has also started, with an investment of 10 million euros, out of the 100 announced last year in the presence of the Spanish Minister of Science. The company is already working on the earthworks, the total estimated execution period will be of 15 months.
The pharmaceutical industry reveals to be one of the strategic sectors that contribute to the economic reactivation of Spain and attracts new international investments to our country, being a driving force for science and the economy, contributing to its revitalization. Each euro invested in this sector generates between one and two in other sectors, and each direct job generates up to four additional ones.
Source: Aragonhoy